Keywords: boehringer, ingelheim, sees, strong, results, tipranavir, data

Boehringer Ingelheim sees strong results for tipranavir

Article | 07 March 2005

Print This

Data from a Phase III study of the investigational anti-HIV drug tipranavir presented at the 12th Conference on Retroviruses and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in